S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Synergy Pharmaceuticals Completes Patient Enrollment for its SP-333 Phase 2 Trial in Patients with Opioid-Induced Constipation|
|Synergy Pharmaceuticals Reports Second Quarter and First Half 2014 Financial Results|
|Synergy Pharmaceuticals Reaches Halfway Mark for the First Pivotal Phase 3 Trial of Plecanatide in Patients with Chronic Idiopathic Constipation|
|Synergy Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for Plecanatide in Irritable Bowel Syndrome with Constipation|
|Synergy Pharmaceuticals to Present at Canaccord Genuity Growth Conference|
|ContraVir Appoints Industry Veteran William Hornung as Its Chief Financial Officer|
|ContraVir to Present at Two Upcoming Investor Conferences|
Click above to view more mutual fund data and stats for sgyp - Synergy Pharmaceuticals Inc.